Large-Scale Study Details Devastating Patient Harms Associated with Blood Culture Contamination
Magnolia Medical Technologies shared a study detailing the clinical and financial impacts of blood culture contamination on patient safety.
Read MorePosted by Andy Lundin | Jan 25, 2023 | Culture Media, Sepsis |
Magnolia Medical Technologies shared a study detailing the clinical and financial impacts of blood culture contamination on patient safety.
Read MorePosted by Andy Lundin | Jan 9, 2023 | Emerging & Zoonotic Diseases, Immunoassay Reagents & test Kits |
BD and CerTest Biotec have announced EUA from the U.S. Food and Drug Administration (FDA) for a molecular PCR assay for Mpox virus detection.
Read MorePosted by Chris Wolski | Jan 9, 2023 | Molecular Diagnostic Analyzers |
PathogenDx’s involvement with Operation Warp Speed, demonstrated the efficacy of microarray technology for diagnostic testing.
Read MorePosted by Andy Lundin | Jan 4, 2023 | Amplification Technologies |
A new CRISPR protein discovery holds potential for the development of new inexpensive and highly sensitive at-home diagnostic tests.
Read MorePosted by Andy Lundin | Dec 30, 2022 | Leukemia |
Alercell is launching a leukemia diagnostic test based on sequencing DNA that will detect up to 51 Genes mutations in Leukemia patients.
Read More